Publikationer

Sortér efter: Dato | Forfatter | Titel

Maceiras, A. R., Silva, M. L., Couto, J., Gonçalves, R., Silva, M., Macedo, S., Machado, D., Indafa, I., Sifna, A., Malaca, C. D., Namara, N. I., Sanca, L., Rodrigues, P. N. S., Viveiros, M., Rudolf, F., Wejse, C., Cá, B. & Saraiva, M. (2025). Activation of nuclear receptors correlates with tuberculosis severity and is a target for host-directed therapy. Frontiers in cellular and infection microbiology, 15, Artikel 1724798. https://doi.org/10.3389/fcimb.2025.1724798
Dutschke, A., Hønge, B. L., Nielsen, T. B., Schjørring, S. & Hansen, K. S. (2025). A fatal incidence of Yersinia enterocolitica meningitis. Diagnostic Microbiology and Infectious Disease, 113(3), Artikel 116940. https://doi.org/10.1016/j.diagmicrobio.2025.116940
Vollmond, C. V., Tetens, M. M., Gerstoft, J., Kronborg, G., Johansen, I. S., Larsen, C. S., Porskrog, A., Dalager-Pedersen, M., Leth, S., Kessing, L. V., Lebech, A.-M., Obel, N. & Omland, L. H. (2025). Bipolar disorder in people with HIV: A nationwide, population-based matched case-control and matched cohort study. AIDS (London, England), 39(3), 253-260. Artikel 04049. https://doi.org/10.1097/QAD.0000000000004049
Lassen, M. C. H., Johansen, N. D., Christensen, S. H., Aliabadi, N., Skaarup, K. G., Modin, D., Claggett, B. L., Larsen, C. S., Larsen, L., Wiese, L., Dalager-Pedersen, M., Lindholm, M. G., Jensen, A. M. R., Dons, M., Bernholm, K. F., Davidovski, F. S., Duus, L. S., Ottosen, C. I., Nielsen, A. B. ... Biering-Sørensen, T. (2025). Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing Cardiovascular Hospitalizations in Older Adults: A Prespecified Analysis of the DAN-RSV Trial. JAMA, 334(16), 1431-1441. https://doi.org/10.1001/jama.2025.15405
Bader-Larsen, K., Nielsen, B. U., Henriksen, E., Bryrup, T., Leo-Hansen, C., Mathiesen, I. H. M., Faurholt-Jepsen, D., Qvist, T., Oturai, P., Langdahl, B., Jeppesen, M., Olsen, H. V., Pressler, T., Skov, M. & Olsen, M. F. (2025). Body mass, linear growth, and body composition before and after the introduction of elexacaftor/tezacaftor/ivacaftor among children and adults with cystic fibrosis. Clinical Nutrition, 54, 132-139. https://doi.org/10.1016/j.clnu.2025.09.008
Pedersen, O. S., Sperling, S., Lillebaek, T., Dahl, V. N. & Fløe, A. (2025). Borderline T-SPOT.TB results: test reliability, patient characteristics, and TB progression. International Journal of Tuberculosis and Lung Disease, 29(9), 422-424. https://doi.org/10.5588/ijtld.25.0178